Related Experiment Video
Updated: Feb 10, 2026

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.7K
Congenital Disorders of Platelet Function and Number
Ruchika Sharma1, Juliana Perez Botero2, Shawn M Jobe3
1BloodCenter of Wisconsin, Medical College of Wisconsin, 8733 Watertown Plank Road, Milwaukee, WI 53226, USA.
Pediatric Clinics of North America
|May 28, 2018
Summary
Congenital platelet disorders cause bleeding and can be linked to other health issues. Identifying the molecular cause helps doctors prevent complications and guide patient care.
Area of Science:
- Hematology
- Genetics
- Pediatrics
Background:
- Congenital platelet disorders present with mucocutaneous bleeding and/or persistent thrombocytopenia.
- These conditions can involve additional hematologic, auditory, immunologic, and oncologic manifestations.
- Disorders follow autosomal recessive, dominant, and X-linked inheritance patterns.
Purpose of the Study:
- To highlight the importance of molecular diagnosis in congenital platelet disorders.
- To emphasize the role of precise molecular delineation in clinical management.
- To inform pediatricians about associated manifestations and anticipatory care.
Main Methods:
- Review of genetic inheritance patterns.
- Analysis of clinical and hematologic manifestations.
- Correlation of molecular causes with clinical outcomes.
Main Results:
- Molecular diagnosis aids in identifying specific disorder-associated risks.
- Understanding inheritance patterns is crucial for genetic counseling.
- Early detection of molecular causes facilitates targeted interventions.
Conclusions:
- Precise molecular characterization of platelet disorders is essential for comprehensive patient care.
- Pediatricians can leverage molecular findings for early detection and prevention of complications.
- Tailored treatment and anticipatory guidance are improved by understanding the molecular basis.
Related Concept Videos
Structure and Function of Platelets
3.7K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.7K
Intrinsically Disordered Proteins
19.6K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K
Formation of the Platelet Plug
9.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.4K
Bone Disorders
5.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.4K
Disorders of Erythrocytes
2.3K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.3K
Disorders of Leukocytes
2.0K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.0K

